GlassScriptPhysician profile
John R Curry
NPI 1790100964
$1,790.45
in general payments reported to CMS, 2019-2025
13 companies · $607 in 2025
The $607 reported for 2025 was more than what 83% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $396 · 2023: $329 · 2024: $458 · 2025: $607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,394.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $782.37 | 2022-2025 | Lifevest |
| Abiomed | $295.39 | 2024-2025 | Impella |
| Atricure, INC. | $183.07 | 2022-2024 | |
| Abbvie INC. | $118.05 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $107.69 | 2022 | |
| Medtronic, INC. | $81.51 | 2024 | Signia |
| Boston Scientific Corporation | $72.35 | 2023 | Watchman Flx |
| Stryker Corporation | $42.55 | 2022 | |
| Fortis Surgical, LLC | $31.89 | 2025 | |
| Getinge USA Sales, LLC | $23.61 | 2023 | Vasoview Hemopro 2 |
| Livanova USA, INC. | $21.53 | 2023 | Lifesparc |
| Davol INC. | $16.34 | 2022 | |
| Edwards Lifesciences Corporation | $14.10 | 2025 | Sapien 3 Ultra Resilia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Curry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.